dasatinib
- Product NDC
- 70771-1905
- 11-digit product format
- 707711905
- Labeler code
- 70771
- Product ID
- 70771-1905_571889d7-845d-4fed-8d7d-6470d4d36fa1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasatinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA218719
- Marketing category
- ANDA
- Marketing start
- 2025-03-03
- Substance
- DASATINIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| RBZ1571X5H | DASATINIB | 863127-77-9 | DASATINIB |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70771-1905-3 | 70771190503 | 30 TABLET in 1 BOTTLE (70771-1905-3) | 30 tablet | 2025-03-03 | No | No | Historical |